Accepting applications beginning June 27, 2018
The Bridge Award supports Phase II SBIR or STTR awardees to advance NHLBI mission-related products to regulatory approval and eventual commercialization. The program promotespartnerships between SBIR/STTR Phase II awardees and third-party investors and/or strategic partners.
Read the full announcement: RFA-HL-19-017
The Small Market Award supports Phase II SBIR or STTR awardees that are developing NHLBI mission-related products that address a rare disease or young pediatric populations. The goal of this FOA is for these products to be further validated so that development can continue with private funding after NHLBI support ends.
Read the full announcement: RFA-HL-19-018
Application: July 27, 2018; by 5:00 PM
Letter of Intent (optional but encouraged): June 27, 2018
Applicants are strongly encouraged to contact the program representative(s) listed in the announcement prior to submitting a proposal.
Gary Robinson, PhD
National Heart, Lung, and Blood Institute (NHLBI)